Kuang Jiangying, Chen Lei, Tang Qin, Zhang Jinhang, Li Yanping, He Jinhan
State Key Laboratory of Biotherapy, Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
Department of Cardiology, The Second Hospital of Shandong University, Shandong University, Jinan, China.
Front Physiol. 2018 Feb 27;9:135. doi: 10.3389/fphys.2018.00135. eCollection 2018.
Sirt6 is one of the sirtuin family members, a kind of NAD+-dependent histone deacetylase and ADP-ribose transferase enzyme. It has an important role in physiological and pathological processes, regulating aging, cancer, obesity, insulin resistance, inflammation, and energy metabolism. Recent studies have suggested that reduced Sirt6 action is related to obesity and diabetes. Aging and overnutrition, two major risk factors for obesity and diabetes, lead to decreased Sirt6 level and function, which results in abnormal glucose and lipid metabolism. Whole-body ablation of Sirt6 in mice results in severe hypoglycemia. Sirt6 deficiency leads to liver steatosis and promotes diet-induced obesity and insulin resistance. Sirt6 has a protective effect on obesity and diabetes. This review surveys evidence for an emerging role of Sirt6 as a regulator of metabolism in mammals and summarizes its major functions in obesity and diabetes.
沉默信息调节因子6(Sirt6)是沉默信息调节因子家族成员之一,是一种依赖烟酰胺腺嘌呤二核苷酸(NAD+)的组蛋白脱乙酰酶和ADP核糖转移酶。它在生理和病理过程中发挥重要作用,调节衰老、癌症、肥胖、胰岛素抵抗、炎症和能量代谢。最近的研究表明,Sirt6活性降低与肥胖和糖尿病有关。衰老和营养过剩是肥胖和糖尿病的两个主要危险因素,会导致Sirt6水平和功能下降,进而导致葡萄糖和脂质代谢异常。在小鼠中全身敲除Sirt6会导致严重低血糖。Sirt6缺乏会导致肝脏脂肪变性,并促进饮食诱导的肥胖和胰岛素抵抗。Sirt6对肥胖和糖尿病具有保护作用。本文综述了Sirt6作为哺乳动物代谢调节因子的新作用的证据,并总结了其在肥胖和糖尿病中的主要功能。